CK Life Sciences releases 2025 Sustainability Report, introduces low-carbon transition plan and publishes first Scope 3 emissions

Bulletin Express
04/17

CK Life Sciences has published its 2025 Sustainability Report, detailing upgraded climate strategy, strengthened ESG governance and new quantitative disclosures.

Key governance moves • The Board retains ultimate oversight, while the Sustainability Committee met twice in 2025 to review policy, targets and performance. • Climate-related risks have been integrated into the enterprise risk management framework; scenario analysis now quantifies potential financial impacts on water and energy costs under net-zero and business-as-usual pathways. • Directors’ remuneration assessments now reference progress against climate metrics.

Decarbonisation roadmap • A company-wide low-carbon transition plan identifies four levers—fuel substitution, resource efficiency, process upgrades and greener supply chain—across nutraceutical, agriculture and salt operations. • Business units have set new targets (base year 2024 unless stated):  – Cheetham aims for a 62% cut in Scope 2 emissions and 65% renewable electricity by 2035;  – Dominion targets 15% reductions in Scope 1+2 emissions and electricity use by 2035;  – Lipa seeks 10% intensity-based GHG and 11% natural-gas intensity reductions by 2032;  – Australian Agribusiness plans 2% electricity-intensity and 10% chemical-washings cuts by 2035.

Emission profile 2025 • Scope 1+2 emissions rose 4% to 49,237 tonnes CO₂e; intensity held at 0.010 tonne per HK$1,000 revenue. • First disclosure of Scope 3 emissions: 164,516 tonnes CO₂e, dominated by purchased goods and services (72%). • Total energy consumption increased 3% to 173.82 million kWh, with natural gas accounting for 46%.

Operational highlights • Regenerative agriculture project completed acquisition of 350,000 hectares in Australia; expected to sequester about one million tonnes CO₂e and generate tradeable Australian Carbon Credit Units. • Lipa opened a probiotic manufacturing facility and became first contract manufacturer to fully implement new TGA probiotic guidelines. • Cheetham converted traditional gas dryers to fluid-bed technology and installed wildlife hydration stations to support local biodiversity. • Vitaquest expanded waste-recycling initiatives, achieving 1,853 tonnes of plastic recovery and launching EV charging on-site.

People and supply chain • 1,521 employees; training coverage rose to 90.2% from 85.7% in 2024. • No work-related fatalities; lost-time injury rate stood at 3.5 per million hours. • Supplier Code of Conduct and modern-slavery controls enforced across a network of 4,953 suppliers, 56.4% located in Australia.

Community investment • Cash and in-kind donations totalled HK$0.62 million, with staff volunteering 56 hours.

The report affirms CK Life Sciences’ commitment to embed climate resilience, responsible innovation and transparent reporting across its diversified life-sciences, nutraceutical and agriculture businesses.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10